These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8400319)

  • 1. Response to P.M. Ravdin (BCRT 24:219-226, 1993), "Evaluation of Cathepsin D as a Prognostic Factor in Breast Cancer".
    Rochefort H; Thorpe S
    Breast Cancer Res Treat; 1993; 26(1):107-11. PubMed ID: 8400319
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of cathepsin D as a prognostic factor in breast cancer.
    Ravdin PM
    Breast Cancer Res Treat; 1993; 24(3):219-26. PubMed ID: 8435477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cathepsin D as prognostic predictor in breast cancer.
    Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
    Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D and prognosis in breast cancer: one piece of a larger puzzle?
    Emmert-Buck MR
    Hum Pathol; 1996 Sep; 27(9):869-71. PubMed ID: 8816879
    [No Abstract]   [Full Text] [Related]  

  • 5. Cathepsin D in breast cancer: a tissue marker associated with metastasis.
    Rochefort H
    Eur J Cancer; 1992; 28A(11):1780-3. PubMed ID: 1389510
    [No Abstract]   [Full Text] [Related]  

  • 6. Cathepsin D: an independent prognostic factor for metastasis of breast cancer.
    Spyratos F; Maudelonde T; Brouillet JP; Brunet M; Defrenne A; Andrieu C; Hacene K; Desplaces A; Rouëssé J; Rochefort H
    Lancet; 1989 Nov; 2(8672):1115-8. PubMed ID: 2572846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.
    Duffy MJ; Reilly D; Brouillet JP; McDermott EW; Faul C; O'Higgins N; Fennelly JJ; Maudelonde T; Rochefort H
    Clin Chem; 1992 Oct; 38(10):2114-6. PubMed ID: 1395002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
    Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
    Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D and breast cancer.
    Westley BR; May FE
    Eur J Cancer; 1996 Jan; 32A(1):15-24. PubMed ID: 8695224
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.
    Brouillet JP; Spyratos F; Hacene K; Fauque J; Freiss G; Dupont F; Maudelonde T; Rochefort H
    Eur J Cancer; 1993; 29A(9):1248-51. PubMed ID: 8343262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of the tumor protease cathepsin D for the biology of breast cancer.
    Dian D; Heublein S; Wiest I; Barthell L; Friese K; Jeschke U
    Histol Histopathol; 2014 Apr; 29(4):433-8. PubMed ID: 24265119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
    Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
    J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin D: association between TN-stage and steroid receptor status of breast carcinoma.
    Nikolić-Vukosavljević D; Grujić-Adanja G; Nastić-Mirić D; Branković-Magić M; Jovanović D; Polić D; Mitrović L
    Tumour Biol; 1998; 19(5):329-34. PubMed ID: 9701723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D and breast cancer: useful?
    Cardiff RD
    Hum Pathol; 1994 Sep; 25(9):847-8. PubMed ID: 8088757
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.
    Maudelonde T; Brouillet JP; Roger P; Giraudier V; Pages A; Rochefort H
    Eur J Cancer; 1992; 28A(10):1686-91. PubMed ID: 1389486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cathepsin-D in patients with breast cancer.
    Winstanley JH; Leinster SJ; Cooke TG; Westley BR; Platt-Higgins AM; Rudland PS
    Br J Cancer; 1993 Apr; 67(4):767-72. PubMed ID: 8471433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
    Lösch A; Kohlberger P; Gitsch G; Kaider A; Breitenecker G; Kainz C
    Br J Cancer; 1996 Jun; 73(12):1525-8. PubMed ID: 8664123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.